Equities

Karadanote Inc

4014:TYO

Karadanote Inc

Actions
Health CareHealth Care Providers
  • Price (JPY)594.00
  • Today's Change4.00 / 0.68%
  • Shares traded4.30k
  • 1 Year change-18.07%
  • Beta2.1160
Data delayed at least 20 minutes, as of Sep 24 2024 01:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Jul 31 2024202420232022
ASSETS
Cash And Short Term Investments4836871,038
Total Receivables, Net275255176
Total Inventory33262.08
Prepaid expenses127101107
Other current assets, total8.570.0234
Total current assets9261,0691,357
Property, plant & equipment, net--00
Goodwill, net------
Intangibles, net2.7000
Long term investments------
Note receivable - long term------
Other long term assets191919
Total assets1,0361,0881,375
LIABILITIES
Accounts payable635937
Accrued expenses2663534
Notes payable/short-term debt--00
Current portion long-term debt/capital leases100100100
Other current liabilities, total49212168
Total current liabilities478406340
Total long term debt200300400
Total debt300400500
Deferred income tax----1.72
Minority interest------
Other liabilities, total5.205.205.21
Total liabilities683711747
SHAREHOLDERS EQUITY
Common stock58309299
Additional paid-in capital428299289
Retained earnings (accumulated deficit)(40)(138)134
Treasury stock - common(94)(94)(94)
Unrealized gain (loss)------
Other equity, total0.000.000.00
Total equity353377629
Total liabilities & shareholders' equity1,0361,0881,375
Total common shares outstanding6.286.246.20
Treasury shares - common primary issue0.110.100.10
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.